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ABSTRACT
￿
The conversion of proglucagon and proinsulin by secretory granules isolated from
both prelabeled and unlabeled anglerfish islets was investigated. Either granules isolated from
tissue labeled with [3H]tryptophan and [14 C]isoleucine or ["S]cysteine, or lysed granules from
unlabeled tissue to which exogenously labeled prohormones had been added were incubated
under various conditions. Acetic acid extracts of these granule preparations were analyzed for
prohormone and hormone content by gel filtration. Both prelabeled and lysed, unlabeled
secretory granules converted radiolabeled precursor peptides (M r 8,000-15,000) to labeled
insulin and glucagon. The accuracy of the cleavage process was established by demonstrating
comigration of products obtained from in vitro cleavage with insulin and glucagon extracted
from intact islets using electrophoresis and high-pressure liquid chromatography (HPLC) . The
pH optimum for granule-mediated conversion was found to be in the range of pH 4.5-5.5.
Conversion of both proglucagon and proinsulin by secretory granules was significantly inhibited
in the presence of antipain, leupeptin, p-chloromercuribenzoate (PCMB) or dithiodipyridine
(DDP) but not chloroquine, diisopropyl fluorophosphate, EDTA, p-nitrophenyl guanidino-
benzoate, soybean trypsin inhibitor, or N-p-tosyl-L-lysine chloromethyl ketone HCI. The
inhibitory action of PCMB and DDP was reversed in the presence of dithiothreitol . Both
membranous and soluble components of the secretory granules possessed significant convert-
ing activity. HPLC and electrophoretic analysis of cleavage products demonstrated that the
converting activities of the membranous and soluble components were indistinguishable. The
amount of inhibition of proinsulin and proglucagon conversion caused by 600 p,g/ml porcine
proinsulin was significantly lower than that caused by the same concentration of unlabeled
anglerfish precursor peptides. These results indicate that the proinsulin and Proglucagon
converting enzyme(s) in the anglerfish pancreatic islet is a unique intracellular thiol protein-
ase(s) that may be granule membrane-associated and may require the presence of prohormone
sequences in addition to the dibasic residues at cleavage sites for substrate recognition and/or
binding.
Although the subcellular conversion of proinsulin to insulin
has been the subject of numerous investigations (1-9), the
mechanisms ofproglucagon biosynthesis and conversion at the
subcellular level have been the focus of only one study. Using
anglerfish pancreatic islet, Noe et al. (7) demonstrated that
both proglucagon and proinsulin are synthesized in the micro-
somes and then transported to the secretory granules. The
appearance of radiolabeled glucagon and insulin in the micro-
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mones to their respective products begins in the endoplasmic
reticulum/Golgi complex. Conversion of both prohormones
was detected in the secretory granules as well, indicating that
the enzyme(s) capable of converting the precursor peptides was
also transported to secretory granules.
In the experiments described herein, the nature of converting
enzyme activity(-ies) was examined in isolated secretory gran-
ules by monitoring the ability of lysed granule preparations to
convert labeled prohormones in the presence or absence of
specific proteinase inhibitors. The possibility that the convert-
ing enzyme(s) may be associated with secretory granule mem-
branes was examined by comparing converting activity of the
membranous and soluble components of isolated secretory
granules. Finally, the selectivity and specificity of the convert-
ing enzyme(s) were assessed by testing the ability of an artificial
substrate, porcine proinsulin, to inhibit the conversion process.
Analysis ofgranule-mediated conversion of prosomatostatin to
somatostatin has been presented in a separate communication
(10). Portions of this work have appeared in the form of an
abstract (11).
MATERIALS AND METHODS
Materials
L-[3H]tryptophan (5.96 Ci/mmol), L-["S]cystine (483.59 Ci/mmol), and L-
["C]isoleucine (296 mCi/mmol) were obtained from New England Nuclear
(Boston, Mass.). 1251-glucagon was obtained from Nuclear Medical Laboratories,
Dallas, Tex. Bio-Gel P-10 (100-200 mesh) and Protein Reagent Kit were pur-
chased from Bio-Rod Laboratories (Rockville Center, N. Y.). Preblend 3a70B
liquid scintillation fluid was obtained from Research Products International (Elk
Grove Village, 111.). Allreagents and embedding medium for electron microscopy
were purchased from Electron Microscopy Sciences (Fort Washington, Pa.).
Proteinase inhibitors, p-nitrophenyl-N-acetyl-ß-D-glucosaminide, and Y-Nucle-
otidase Reagent Kit were obtained from Sigma Chemical Co. (St. Louis, Mo.).
Antipain and leupeptin were gifts from Dr. Walter Troll, NewYork University
Medical Center andthe Japanese-American CancerProgram,NewYork. Porcine
proinsulin was generously supplied by Dr. Ronald Chance, Lilly Research
Laboratories, Indianapolis, Ind.
Incubation of Islet Tissue
Pancreatic islets were removed from anglerfish (Lophius americanus) obtained
at the Marine Biological Laboratory, Woods Hole, Mass. After decapsulation,
islet tissue was either sliced into 2-mm' pieces for incubation or homogenized in
1.0 ml of 0.25 M sucrose containing l MM MgC12 for fractionation. Tissue slices
were subjected to a 30-min preincubation at 20°C in 3.0 ml of Krebs-Ringer
bicarbonate buffer (KRB), pH 7.4, under 95% 02/5% C02. After removal of the
preincubation medium, the tissue was incubated in I-2 ml of KRBcontaining
100 gCi of [3H]tryptophan and either 10 ,uCi of ["C]isoleucine or 50 pCi of
reduced ["S]cystine. After various periods of incubation, islet tissue was washed
twice with fresh KRB and thenhomogenized in 0.25 msucrose containing 1 mM
MgC12.
Subcellular Fractionation
Fractionation ofthe islet tissue was performed as previously described by Noe
et al. (12), except that all sucrose solutions contained I MM MgC12 to maintain
ribosomal integrity and association with microsomal membranes. This procedure
resulted in seven subcellular fractions: F-I (nuclei); F-IIT (mitochondria); F-í1M
(mitochondria, cell debris); F-IIB (secretory granules 220-310 nm in diameter);
F-í1I (microsomes); F-íííc (secretory granules 150-200 nm in diameter); and F-
IV (postmicrosomal supemate). For most of the experiments performed in the
present study, the two secretory granule fractions (F-IIB +F-IIIc) were combined
and sedimented by centrifugation for use in conversion assays.
Incubation of Isolated Secretory Granules
Secretory granules were suspended in 0.02 M sodium acetate-acetic acid
buffer, pH 5.2, and then gently mixed by hand in a Potter-Elvejhem homogenizer
(Kontes Co., Vineland, N. J.). For some experiments, granules were suspended
in acetate-buffered 0.25 Msucrose. Conversion ofboth endogenously and exog-
enously labeled precursors was examined. For endogenous conversion experi-
ments, secretory granules that had been isolated from previously radiolabeled
tissue were incubated at 30°C for a specified period of time. For exogenous
conversion experiments, unlabeled granule fractions were rapidly frozen and
thawed six times to lyse the granules and were then incubated at 30°C with
labeled prohormones obtained by gel filtration of extracts from tissue incubated
separately with radiolabeled amino acids. Peptides recovered from the M, 8,000-
15,000 portion ofthe gel filtration fractionation range (prohormones,prohormone
conversion intermediates, and minute amounts of nonhormonal proteins) were
lyophilized, suspended in 0.04 M acetic acid, and then adjusted to pH 5.2 with
0.2 M sodium acetate before incubation with unlabeled granule preparations.
The incubation procedure was established after performing experiments to deter-
mine the pH and temperature optima for conversion in isolated granules and
experiments to compare the time-course of conversionin intact tissue and isolated
granules. Anglerfish are isothermic at 4°-10°C. Incubation of intact tissue at
temperaturesabove 20°Cinhibitsprotein synthesis. The time-course ofproinsulin
and proglucagon conversion in intact tissue incubated at 20°C was paralleled
closely by conversion in granules incubated at 30°C, with insulin and glucagon
accumulation reaching a plateau between 3 and 6 hof incubation. Intact or lysed
secretory granules were therefore incubated for 6-8 h at 30°C to assure that the
conversion reactions had sufficient time to reach completion.
To examine the effects of various proteinase inhibitors on conversion, the two
granule fractions isolated from labeled tissue were combined, diluted in 0.25 M
sucrose, and precipitated by centrifugation. The granules were suspended in
sodium acetate buffer (pH 5.2) and then frozen and thawed six times. Aliquots
of the lysed granule preparations were then either extracted immediately or
incubated for 6 h at 30°C in the presence or absence of specific inhibitors. All
inhibitors were prepared just before incubation with the granules.
Extraction Procedure and Gel Filtration
Islet peptides were extracted with 2 M acetic acid as described by Noe et al.
(13). Extracts were filtered on columns (1.6 cm x 90 cm) of Bio-Gel P-10 (100-
200 mesh) in 2M acetic acid at ambient temperature and 1.5-ml fractions were
collected. Monitoring of the eluate for absorbance at 280 nm, determination of
the distribution ofradioactivity, and computation of double-label data were all
performed as previously described (14). Copies ofboth the eluate chromatograms
and the normalized data were made by use of a Tektronix hard-copy unit and
retained for use in calculating hormone accumulation.
Determination of Percent Conversion
Evaluation of conversion ofproglucagon and proinsulin was based on differ-
ential labeling of islet peptides. Tryptophan is incorporated into anglerfish
proglucagon, glucagon,prosomatostatin, and somatostatin but not into proinsulin
(10, 13-15). Percent accumulation ofglucagon was obtained by calculation ofthe
ratioof'H radioactivity in the M, 2,500-6,000 portion of the gel filtration eluates
to total post-void volume 'H radioactivity. It has been demonstrated previously
that 81% ofthe [3H]tryptophan-induced disintegrations per minute (dpm) eluting
in M. 2,500-6,000 portion of the fractionation range can be attributed directly to
labeled glucagon, monodesamidoglucagon and a M, 4,900 glucagon immuno-
reactive peptide presumed to be a conversion intermediate between proglucagon
and glucagon (7, 15). Total post-void volume 'H dpmwere used rather than the
'H dpm that elute at Mr 11,000-13,500, because it is now known that prosoma-
tostatin (M, 13,328), which also contains tryptophan, coelutes with proglucagon
under the conditions employed (10, 16). Thus, the relative contribution of each
of these prohormones to the total'H label eluting at M, 11,000-13,500 cannot be
readily determined. Finally, it would not be acccurate to include void volume
radioactivity because it has been concluded that the radioactive peptides eluting
in the P-10 void volume are not involved in islet hormone or prohormone
synthesis (17). Therefore, the expression of glucagon accumulation chosen was:
%accumulation ofglucagon =[(3HdpmM, 2,500-6,000)/(total post-void volume
'H dpm)] x 100. As an example oftotal post-void volume dpm, the H dpm in
fractions 38-120 in Fig. 2 were used. Although this computation method under-
estimates "% conversion" ofproglucagon, comparisonof%accumulation between
control and experimental incubations remains valid because each was calculated
using the same method.
Using ["C]isoleucine or reduced ['S]cystine, anglerfish proinsulin and insulin
are selectively labeled and clearly defined as separate "C-or "S-labeled peaks in
Bio-Gel P-10 filtration eluates; glucagon lacks both amino acids andsomatostatin
lacks isoleucine (l3, 14). Percent accumulation of insulin was obtained by
summation of the dpm in the proinsulin and insulin peaks, then use of the
formula: %accumulation of insulin = [(1"C or 35Sdpminsulin)/('"C or "S dpm
proinsulin + insulin)] x 100.
In those experiments involving the use of proteinase inhibitors, results were
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313expressed as percent inhibition, according to the formula: % inhibition = l -
[(% accumulation in the test incubation)/(% accumulation in the control incu-
bation)] x 100. Prelabeled secretory granules were employed in the experiments
testing the effects of proteinase inhibitors. To normalize the percent conversion
in the test and control incubations to the "zero time" level, the percent accumu-
lation of insulin and glucagon found in an extract ofan aliquot oflysed granules
not subjected to incubation was subtracted from accumulation in both control
and inhibitor-containing postincubated samples before the percent inhibition
calculation was performed. Results were subjected toa one-tailed Student's t test
using zero (% inhibition) as the test statistic.
Polyacrylamide Gel Electrophoresis (PAGE)
Gel electrophoresis wasperformed on 1.5-mmslab gels of 10% polyacrylamide
at alkaline pH by the method ofDavis (18). Afterelectrophoresis, geltracks were
excised, frozen, and sliced into 2-mm slices. These were eluted in 1.5 ml of 1 M
propionic acid for 48 h. Aliquots were assayed for distribution ofradioactivity or
immunoreactive insulin (12) and glucagon (14) as previously described.
High-pressure Liquid Chromatography (HPLC)
The HPLC apparatus consisted of a Perkin-Elmer (P-E) Series 3B liquid
chromatograph (Perkin-Elmer Corp., Instrument Div., Norwalk, Conn.) linked
to a P-E LC-75 spectrophotometer and a P-E Sigma 10 chromatography data
station. Reverse phase HPLC was performed with a 0.46 x 15 cm Supelcosil LC-
18 column (Supelco Inc., Bellefonte, Pa.), using 0.25 N triethylammonium
phosphate, pH 3.0, containing 21% (vol/vol) acetonitrile (19). Samples were run
at ambient temperature with a flow rate of 1.5 ml/min and a column pressure of
1,350 psi. After sample injection, the run was continued for 10 min at 21% (vol/
vol) acetonitrile. At this point, a linear gradient which reached 30% (vol/vol)
acetonitrile in 30 min was begun. A 5-min period at 30% CH3CN, followed by a
5-min linear gradient to 60% CH3CN, and a 10-min gradient returning to the
initial conditions completed each chromatography run.
Enzyme and Protein Assays
5'-Nucleotidase (EC 3.1.3.5) was used as a marker enzyme for the plasma
membrane. It was assayed according to the procedureofDixon and Purdom (20).
Activity units are micrograms of phosphate released per hour at 37°C. P-N-
Acetylglucosaminidase (EC 3.2.1.30) was employed as a marker for lysosomes
and was assayed according to Sellinger et al. (21) as modified by Unkeless et al.
(22), using p-nitrophenyl-N-acetyl-P-D-glucosaminide as the substrate. Activity
units are nanomoles ofp-nitrophenol released per hour at 37°C.
Determination of protein content was made by the method of Bradford (23),
using bovine gamma globulin standards.
Electron Microscopy
Secretory granules were sedimented by centrifugation (142,000 g, 30 min) and
fixed for 1.5 h at 4°C in 1.5% (vol/vol) glutaraldehyde in 0.1 M sodium phosphate
buffer, pH 7.2. Granules were then postfixed in 2.0% (wt/vol) osmium tetroxide
in the same buffer, dehydrated through a graded series ofethanol and propylene
oxide, and embedded in Epon. Thin secretions were cut with a Porter-Blum
Sorvall MT-2 (Ivan Sorvall, Inc., Norwalk, Conn.), stained with uranyl acetate
and lead citrate, and examined with a Philips 300 electron microscope.
RESULTS
Enzyme Activities of Subcellular Fractions
The distribution oflysosomal and plasma membrane enzyme
markers recovered from the subcellular fractions is shown in
Fig. 1 . The nuclear and two mitochondrial fractions (F-11T and
F-IIm) contained 59.9% of the ß-N-acetylglucosaminidase ac-
tivity, with 37.6% present in the F-11T fraction. The lowest
amounts of this enzyme were found in the microsomes and
secretory granules; in fact, the combined activities of the two
secretory granule fractions (F-IIB and F-III) comprised only
9.9% of the total activity recovered, whereas the microsomes
(F-III) contained 12.3%.
The nuclear (F-I), mitochondrial (F-11T and F-Hm) and
microsome (F-III) fractions were found to contain 81 .7% ofthe
5'-nucleotidase activity. The nuclear fraction contained 28.4%
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FIGURE 1 Subcellular distribution of enzyme activities. Aliquots
were taken from the seven subcellular fractions and assayed for the
presence of specific enzyme activities as described in Materials and
Methods. Results are expressed as mean values (t SE) of specific
activity (activity units of enzyme per milligram of protein) for six
determinations. N-Ac-ease, ,ß-N-acetyglucosaminidase; 5'-ND, 5'-
nucleotidase. Numbers in parentheses are percent of total activity
recovered in each fraction.
of the total activity. This is attributed to the presence of
unbroken cells in this fraction (12). The microsome fraction
contained 25.4% of the recovered activity and the combined
secretory granule fractions (F-IIB and F-111c) contained only
7.7%. Together with the finding that most of the immunoreac-
tive insulin, glucagon, and somatostatin is recovered in the
granule fractions (10), these results demonstrate that contami-
nation of the secretory granule preparation with other subcel-
lular components is very low.
Determination of Optimum pH for Conversion
The data from determination of the optimum pH for con-
version are shown in Figs. 2 and 3. Secretory granules were
isolated from tissue incubated for 2 h with [3H]tryptophan and
[t'C]isoleucine and prepared for incubation as described in the
legend of Fig. 2. After the granules were frozen and thawed,
electron microscopic examination showed that -r95% of them
were lysed (results not shown). In Fig. 2B-D, the gel filtration
elution patterns typically observed after incubation at three of
the tested pH values are shown for comparison with the pattern
obtained from granules extracted immediately after isolation34,0
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FIGURE 2
￿
Effects of pH on islet prohormone conversion in secretory
granules. Secretory granules were isolated from tissue incubated for
2 h with [3H]tryptophan ([3H]TRP) and [14C]isoleucine (['"C]ILE) .
Granules were suspended in 0.25 Msucrose, dispersed with homog-
enization by hand, and lysed by freezing and thawing six times.
One aliquot was extracted immediately (nonincubated control). To
remaining aliquots, an equal volume of 0.04 M sodium acetate-
acetic acid buffer at pH 3.0, 4.0, or 5.2; or 0.04 M potassium
phosphate buffer at pH 6.0, 7.5, or 9.0 was added and the prepara-
tions were incubated for 8 h at 30°C. Acetic acid extracts of each
sample were subjected to gel filtration on Bio-Gel P-10 to determine
insulin and glucagon accumulation at each pH value. A, Filtration
pattern from extract of granules extracted immediately after isolation
(nonincubated control) ; 8, extract of granules incubated at pH 3.0;
C, extract of granules incubated at pH 5.2; D, extract of granules
incubated at pH 9.0; solid line, [3H]tryptophan; dashed line,
['°C]isoleucine. Markers: Vo, void volume; AFI, AFG, AFS, elution
positions of anglerfish insulin, glucagon, and somatostatin, respec-
tively.
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FIGURE 3
￿
Determination of optimal pH for islet prohormone con-
version in secretory granules. Secretory granules were isolated from
labeled tissue, then resuspended and incubated as described in Fig.
2. After gel filtration of the resulting extracts, insulin and glucagon
accumulation in excess of that found in nonincubated controls were
determined as described in Materials and Methods and are ex-
pressed here as percent product. Data are mean (t SE) of two
determinations. ", Insulin; ", glucagon.
(Fig. 2A). Prohormones and conversion intermediate(s) elute
in the Mr 15,000-8,000 portion of the fractionation range
(fractions 38-60). In Fig. 2, 3H-labeled proglucagon and pro-
somatostatin elute near fraction 40 and "C-labeled proinsulin
elutes near fraction 46 (1, 7, 10-17). The 3H-labeled material
that elutes near fraction 58 (Fig. 2 B and C) indicates the
presence of prohormone conversion intermediates (14, 17). As
seen in Figs. 2 B and D, accumulation of
1"C-labeled insulin,
and 3H-labeled glucagon and somatostatin (7, 10, 13, 14) was
insignificant at pH 3.0 and pH 9.0. At pH 5.2, however,
accumulation ofall three hormones was pronounced (Fig. 2 C).
The elution patterns obtained at pH 5.2 were indistinguishable
from those obtained from extracts of intact tissue (7, 10, 13,
14), or secretory granules isolated after pulse incubation and
protected from lysis by suspension in 0.25 .M sucrose during 6-
to 8-h chase incubations. The data on hormone accumulation,
obtained after incubation oflysed secretory granules in buffers
at six different pH values, are summarized in Fig. 3. Conversion
of proinsulin and proglucagon was found to be optimal be-
tween pH 4.5 and 5.5. The pH profile for somatostatin accu-
mulation in the same experiments parallels the profiles shown
in Fig. 3 (10).
By monitoring recovery of immunoassayable hormones in
the media after incubation of freshly prepared granules in
buffers at the pH values shown in Fig. 3, it was found that
both a and ß cell granules were most stable in the pH 4.5-5.5
range as well. Only 2.1% of the total immunoreactive insulin
and 2.3% of the immunoreactive glucagon were found in the
media after incubation at pH 5.2. The pH optimum for con-
version and granule stability is significantly different from that
for proteases in the cytosol and particulate fractions of angler-
fish islet that degrade insulin and glucagon. Degradation of
125I-insulin and 1251-glucagon, monitored by loss of TCA-pre-
cipitable radioactivity, was found to be optimal at pH 3.4 and
pH 7.3.' As shown in Fig. 2 B, some prohormone degradation
occurred, but little accumulation of insulin, glucagon, and
somatostatin was observed after incubation at pH 3.0. In vitro
' G. E. Bauer, manuscript in preparation. Abstract: 1980, BioL Bull.
(Woods Hole). 159:473.
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6.8 7.2conversion at pH 7.5 was even lower than that at pH 3 (Fig. 3).
These results suggest that the precursor degradation observed
at pH 3.0 and pH 7.5 was mediated to some extent by nonspe-
cific or lysosomal proteases different from the converting en-
zyme(s).
Conversion of Exogenously
Labeled Prohormones
It was assumed that labeled prohormones added to prepa-
rations of intact secretory granules would not readily pass
through granule membranes to gain access to the converting
enzyme(s). Indeed, conversion of labeled precursors added to
unlysed secretory granules suspended in sodium acetate-
buffered 0.25 M sucrose (pH 5.2) was found to be minimal;
hormone accumulation was <5%. Because some of the pro-
posed studies required the use of exogenously labeled precur-
sors, it became necessary to determine: (a) whether unlabeled
lysed granules could mediate exogenously labeled prohormone
conversion, and (b) ifconversion occurred, whether the "prod-
ucts" generated represented accurate cleavage products. In Fig.
4, prohormone conversion in granules isolated from labeled
tissue (Fig. 4A) is compared with conversion of exogenously
labeled precursors by an unlabeled lysed granule preparation
(Fig. 4 C. Fig. 4 B shows the elution pattern of an extract
prepared immediately after mixing labeled (exogenous) pro-
hormones with lysed, unlabeled secretory granules. No radio-
labeled hormones were present in the filtration eluate, indicat-
ing that neither nonspecific degradation nor conversion oc-
curred during the preparation of the precursor peptides. When
labeled prohormones were incubated for 6 h in buffer alone,
the gel filtration pattern of the resulting extract was identical
to that in Fig. 4 B (not shown). When the lysed granule-
prohormone mixtures were incubated for 6 h at 30°C,
14C_
labeled insulin and 3H-labeled peptides having elution posi-
tions ofglucagon-related peptides and somatostatin (10, 13-15)
appear (Fig. 4 C). Concomitant with the increased radiolabel-
ing of the smaller peptides, there is a diminution of both 3H
and `"C radioactivity in the precursor peptides. The elution
patterns generated by granule-mediated conversion of both
endogenously and exogenously labeled prohormones were in-
distinguishable from those obtained in extracts of intact tissue
subjected to continuous or pulse-chase incubation (10, 13-15).
Three types of control experiment were performed. In the
first two, labeled precursor peptides were incubated with rat
liver homogenate or postmicrosomal supernate (F-IV) from
anglerfish islet at pH 5.2. Although nearly complete degrada-
tion of labeled prohormones occurred in both types of incu-
bation, accumulation ofinsulin, glucagon, or somatostatin was
not observed in gel filtration eluates (data not shown). These
results suggest that the prohormones and products were hydro-
lyzed by nonspecific proteases present in islet cytosol and rat
liver homogenate. Incubation of labeled precursors with lysed
islet secretory granules under the same conditions consistently
yielded readily identifiable products (Fig. 4 C. In the third
type of control experiment, the fraction containing the greatest
amount of lysosomal enzyme activity (F-IIT, Fig. 1) was tested
for the ability to convert islet prohormones at pH 5.2. For these
incubations the F-IIT protein:prohormone protein ratios were
adjusted to one-half, equal to, and three times the secretory
granule protein:prohormone protein ratios employed for the
experiment in Fig. 4 B and C. The F-IIT material was lysed by
freezing and thawing, and the incubation conditions were the
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FIGURE 4 Conversion of radiolabeled prohormones to hormones
by secretory granules. A, Secretory granules were isolated from islet
tissue incubated for 3 h in the presence of [3H]tryptophan ([3H]-
TRP) and ["C]isoleucine (['"C]ILE), After suspension in 0.02 M
sodium acetate buffer, pH 5.2, granules were incubated for 7 h at
30°C and then extracted with 2 M acetic acid . The distribution of
radioactivity in the eluate after P-10 gel filtration is shown. B and C,
Secretory granules isolated from unlabeled islet tissue were sus-
pended in 0.02 M sodium acetate buffer, pH 5.2, then lysed by
repeated freezing and thawing. Exogenously radiolabeled prohor-
mones were obtained as described in Materials and Methods. Ali-
quots of the precursor preparation were combined with aliquots of
the lysed granules and either extracted immediately with 2 M acetic
acid (B) or allowed to postincubate for 6 h at 30°C (C) before
extraction and gel filtration . ", [3H]tryptophan; A, ['°C]isoleucine.
Markers: Vo, void volume; AFI, AFG, and AFS, elution positions of
anglerfish insulin, glucagon, and somatostatin, respectively.
same as in Fig. 4 C. Gel filtration analysis of the incubates
showed that: (a) although 3H-labeled prohormones were de-
graded, proinsulin was very resistant to degradation, (b) the
labeled "products" generated could not be identified as insulin,
glucagon, or somatostatin on the basis of molecular size, and
(c) the chromatographic profiles that resulted from incubations
at all concentrations of F-IIT material were distinctly different
from those seen in Figs. 2 C and 4 C, where conversion of
endogenously and exogenously labeled prohormones, respec-
tively, is shown.
Assessment of the Accuracy of Cleavage
To determine whether the products generated during in vitro
conversion ofexogenously labeled prohormones were accurate
cleavage products (i.e., insulin- and glucagon-related peptides),
the peptides eluting in the Mr 2,500-6,500 range of P-10 column
filtrates were subjected to high-pH PAGE and reverse-phase
HPLC. The electrophoretic mobilities of the products fromintact islet tissue are shown in Fig. 5A . The major t4C-labeled
component (fractions 16-19) was identified as anglerfish insu-
lin, because it comigrated with the only detectable immuno-
reactive insulin eluted from the gel slices . Glucagon (fractions
8-11) and desamidoglucagons (fractions 21-26) were identified
on the basis of tryptophan content and glucagon immunoreac-
tivity . The 2 M acetic acid extraction and gel filtration proce-
dures employed to recover somatostatin (10, 13, 17) promote
selective deamidation of glucagon, which increases its electro-
phoretic mobility. This accounts for the difference in the
pattern shown in Fig . 5A as compared with those obtained
when extraction is in acid ethanol and gel filtration is per-
formed using 1 M acetic acid (14, 15) . The enhanced mobility
is in accordance with the results of Bromer et al. (24), who
examined the electrophoretic mobility of deamidated gluca-
gons at high pH using 200 Io acrylamide gels . Somatostatin is
highly basic and migrates to the cathode under the conditions
employed (10, 13, 17) .
Labeled prohormones recovered from the same extract as
the insulin and glucagon used in Fig. 5 A were incubated 2 h
in the presence of a lysed secretory granule preparation . Insu-
lin- and glucagon-related peptides recovered from the P-10
filtrate of the resulting extract were run on the same slab gel as
the products from intact tissue (Fig. 5 B) . The mobility of "C-
insulin generated by granule-mediated cleavage of labeled
prohormones was identical to insulin from intact tissue . Al-
though it is apparent that the deamidated components predom-
inate, the mobility of the glucagon-related peptides correlates
precisely with those from intact tissue as well . It was found
that increasing the duration of exposure of labeled prohor-
mones to lysed secretory granules did not alter the electropho-
retic mobility of insulin but promoted increased deamidation
of glucagon . After 4 or 6 h of incubation, the primary [ 3H]-
tryptophan-labeled glucagon immunoreactive component was
the most rapidly migrating peptide (i.e ., fractions 24-26).
HPLC retention times of these products were consistent with
the observed progressive deamidation of glucagon (data not
shown).
The demonstration that the in vitro products cannot be
distinguished from insulin- and glucagon-related peptides from
intact tissue confirms that the secretory granule converting
assay system provides a viable means for characterizing con-
verting activity. In accordance with the results of Sorenson et
al. (3), conversion ofexogenous precursors was found to be less
efficient than conversion of endogenous prohormones . This
was probably because of substrate competition by unlabeled
precursors in exogenous conversions in which the entire secre-
tory granule content was unlabeled.
Converting Activity of Membranous and Soluble
Components of Secretory Granules
To assess the relative converting activities of the membra-
nous and soluble subfractions from granules, in vitro conver-
sion assays were performed using exogenously labeled prohor-
mones. Both membranous and soluble components of islet
secretory granules were found to have significant prohormone
converting activity (Table I) . Both the membranous and the
soluble converting activities were inhibited significantly by 300
ug/ml leupeptin (see next section) . To obtain a more accurate
comparison of prohormone converting activity between the
s B . D . Noe, unpublished observations .
FIGURE 5 Comparison of the electrophoretic (polyacrylamide gel
electrophoresis, PAGE) mobilities of insulin and glucagon extracted
from intact islet tissue with products generated from conversion of
prohormones mediated by lysed secretory granules . A, Labeled
insulin- and glucagon-related peptides were recovered from the gel
filtrate of an acetic acid extract of 73 mg of islet tissue incubated for
5 h with [3H]tryptophan ([ 3H]TRP) and [14C]isoleucine ([' 4C]ILE)
and subjected to high pH PAGE . Gel slices were eluted and aliquots
were taken for determination of the distribution of radioactivity and
immunoreactive insulin and glucagon . Anglerfish insulin con-
sistently eluted from slices 16-18 . Glucagon and desamidoglucagons
(see text and reference 24) eluted from slices 8-11 and 21-26,
respectively . B, Labeled precursors were recovered from the same
filtrate as in A above . The lyophilized prohormones were suspended
as described in Materials and Methods and incubated at pH 5 .2 for
2 h with aliquots of a lysed unlabeled secretory granule preparation .
Acetic acid extracts were gel filtered and the insulin- and glucagon-
containing portions of the eluate recovered for PAGE . The distri-
bution of products generated by granule-mediated conversion co-
incides precisely with those extracted from intact tissue after a pulse
incubation . Solid line, [3H]tryptophan ; dashed line, ['
4C]isoleucine ;
stippled area, distribution of immunoreactive glucagon (right inner
scale, pg/slice) brackets, areas in which single peaks containing 22 .9
lAg (A) and 4.6gg (B) of immunoreactive insulin (IRI) were present ;
T, position of the tracking dye .
membranous and soluble components, "relative specific con-
verting activity" was estimated by expressing percent accu-
mulation ofglucagon or insulin per milligram ofmembrane or
supernate protein (Table I) . When expressed in this manner, it
appears that proinsulin was more readily converted than pro-
glucagon by both the membranous and the soluble granule
components in this in vitro system . It is most important to note,
however, that even though the "specific converting activity" of
the soluble subfraction was significantly greater than that of
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Conversion of Prohormones by Membranous andSoluble Components of Secretory Granules
Relative specific converting
activity§
Supernate$ or mem-
Component
￿
Glucagon
￿
Insulin
￿
brane protein
￿
Proglucagon
￿
Proinsulin
Percent accumulation*
Supernate
￿
15.9 t 3.9 (4)
￿
34.3 t 10.4 (4)
￿
0.34 mg
￿
46.7
￿
100.8
Membrane
￿
21.5 t 4.0 (4)
￿
36.6 ± 11 .6 (4)
￿
0.77 mg
￿
27.9
￿
47.5
Secretory granules from 60-80 mg of unlabeled tissue were isolated and lysed by freezing and thawing. Membranous components were separated from soluble
components as described in Fig. 6. Each component was incubated with labeled prohormones for 6 h in equal volumes of buffer.
' Mean (t SE) percent accumulation determined as described in Materials and Methods for the number of observations in parentheses.
$ Mean granule supernate and membrane protein assayed before incubation with exogenous prohormones. Prohormone content in all membrane and supernate
incubations wasequivalent.
§ Relative specific converting activity for proglucagon and proinsulin by membranous and soluble components was obtained by dividing the mean percent
accumulation of product by the mean granule membrane or supernate protein content.
the membrane subfraction for both prohormones, the mem-
brane subfraction clearly possesses some detectable converting
activity.
However, it is possible that converting enzyme(s) may be-
come nonspecifically adsorbed to the granule membranes after
granule lysis. To further investigate this possibility, we sub-
jected two identical granule membrane preparations to three
successive washes in 0.04 M sodium acetate buffer, pH 5.2. For
one of the membrane preparations, the second wash was per-
formed in buffer brought to 100 mM KCI. This should promote
the dissociation of adsorbed materials (see Discussion). After
incubation of the two washed membrane preparations with
labeled prohormones, the relative converting activities of the
two preparations were compared. The accumulations ofinsulin
and glucagon generated by the membrane preparation washed
in KCI were only 16% and 5% lower, respectively, than those
induced by the membranes washed in buffer only. These results
suggest that a portion of the converting enzyme(s) in secretory
granules is membrane associated.
Reverse-phase HPLC was used to analyze and compare the
products ofgranule membrane- or supernate-mediated conver-
sion (Fig. 6). Products generated from incubation with super-
nate (Fig. 6A) or membranes (Fig. 6 B) were identical. The 1°C
label eluting at 42 min on HPLC was identified as insulin,
based on coelution of immunoreactive insulin (Fig. 6 B) and
partially purified anglerfish insulin (Fig. 6 C). Deamidated
glucagons eluted at 28 and 32 min (Fig. 6A and B). Moreover,
PAGE analysis of the products from both supernate- and
precipitate-mediated conversion produced electropherograms
identical to those obtained from nonfractionated lysed granule
preparations (i.e., Fig. 5 B).
Effects of Proteinase Inhibitors on Conversion
Islet tissue (150-200 mg) was incubated for 2.5-3 h in the
presence of radiolabeled amino acids before fractionation.
After lysing the secretory granules, we took one aliquot for
immediate extraction and incubated the remaining aliquots for
6 h in the presence or absence of specific proteinase inhibitors.
Leupeptin and antipain, which are arginine-containing peptide
aldehydes (25), caused a significant reduction in both proglu-
cagon and proinsulin converting activities (Table II). The thiol
proteinase inhibitors 2,2'-dithiodipyridine (DDP) and p-chlo-
romercuribenzoate (PCMB) also significantly inhibited both
converting activities but did not alter the gel filtration elution
position of either proglucagon or proinsulin. The inhibitory
effects of PCMB and DDP were prevented when dithiothreitol
(DTT), a reducing agent, was present in the incubations.
Moderate inhibition of converting activity was also obtained
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in the presence ofL-tosylamide-2-phenylethylchloromethyl ke-
tone (TPCK), an inhibitor ofchymotrypsin. Inhibitorsofserine
proteinases (diisopropyl fluorophosphate [DFP], p-nitro-
phenylp'-guanidinobenzoate [NPGB], and soybean trypsin
inhibitor [STI]) and metalloenzymes (EDTA) had no signifi-
cant effect. Chloroquine and Np-tosyl-L-lysine chloromethyl
ketone HCl (TLCK), inhibitors of cathepsin B (26, 27), also
failed to inhibit converting activity.
To determine whether the nontoxic inhibitors antipain and
leupeptin could inhibit conversion in intact tissue, they were
included in incubation media during 5-h incubations of islet
tissue in the presence of radiolabeled amino acids. Both anti-
pain and leupeptin caused an inhibition of prohormone-to-
hormone conversion (Table III). The rate of protein synthesis
was not affected by the inhibitors. The level of inhibition
ranged from 22 to 25% when antipain or leupeptin was used
singly at 500 ,pM. If antipain and leupeptin were combined at
500 ,,M each, inhibition of hormone accumulation was more
effective. These results demonstrate that antipain and leupeptin
can be assimilated and that these inhibitors interfere with
prohormone-to-hormone conversion in intact islet tissue.
Competitive Effects of Natural and
Artificial Substrates
Other than the fact that cleavage occurs at dibasic amino
acid residues, there is currently very little information available
regarding the enzyme-substrate interactions between convert-
ing enzyme(s) and prohormones. To test the hypothesis that a
segment ofpolypeptide chain separate from the dibasic residue
site may also be necessary for converting enzyme recognition
of, and/or binding to prohormones, the relative abilities of
unlabeled anglerfish islet precursors and an artificial substrate
(porcine proinsulin) to inhibit labeled prohormone conversion
were compared. In the absence of sufficient quantities of a
purified anglerfish islet prohormone to use as a natural sub-
strate, the precursor pool (Mr 8,000-15,000) that contains all of
the islet prohormones was employed. However, for the pur-
poses of these experiments, this is actually advantageous. All
ofthe anglerfish islet prohormones are slightly larger in molec-
ular size than porcine proinsulin (7, 13, 14, 16, 17). Therefore,
1 frg ofporcine proinsulin should contain more dibasic residues
(more molecules) for converting enzyme recognition than 1 hg
of the anglerfish islet prohormone mixture.
Identical quantities (by weight) ofartificial substrate,natural
substrate (unlabeled), or bovine serum albumin (BSA) were
included in incubations with lysed granules plus labeled pre-
cursors. BSA at 600 f-tg/ml had no effect on converting activity.FIGURE 6
￿
HPLC analysis of cleavage products generated by incu-
bation of exogenously labeled prohormones with granule mem-
branes and granule sol . Secretory granules prepared from 70 mg of
islet tissue were suspended in 375 )il of sodium acetate buffer (pH
5.2), dispersed with homogenization by hand, and then subjected
to repeated freezing and thawing to disrupt granule membranes.
Membranes were separated from soluble components of the gran-
ules by centrifugation of the lysate in a 2-ml tube for 30 min at
40,000 rpm using a Beckman 50 rotor . The supernate was removed
and the membranes were washed by agitation in 100 Ml of acetate
buffer and subjected to recentrifugation . After resuspension and
dispersion of thegranule membranes in avolume of sodium acetate
buffer equal to that of the pooled supernates, aliquots were taken
for protein determination ; then each subfraction was incubated
with an aliquot of the same labeled precursor preparation for 4 h .
Acetic acid extracts of the incubates were subjected to gel filtration
and the M r 2,500-6,500 portion of theeluate was recovered, lyoph-
ilized, and suspended in 500 WI of 3M acetic acid for HPLC analysis .
A, supernate; B, membranes ; C, anglerfish insulin purified as de-
scribed in reference 15 . AUFS, absorbance units full scale ; absorb-
ance resulting from 500 ILI of 3 M acetic acid alone has been
subtracted . Solid line, [aH]tryptophan ; ([ 3H]TRP) dashed line,
[' °C]isoleucine (['°C]ILE) ; stippled area, distribution of immuno-
reactive glucagon (left inner scales, pg/1-min sample); cross-hatched
area, distribution of immunoreactive insulin (right inner scale, fig/1-
min sample) ; arrow, sample injection mark.
The presence of porcine proinsulin in the incubation mixture
inhibited accumulation of both glucagon and insulin (Fig . 7).
However, for conversion of both proinsulin and proglucagon,
the amount of inhibition caused by 600 Fig/ml unlabeled
precursors was significantly greater than that caused by the
same amount ofporcine proinsulin. The addition of 300 fig/ml
porcine proinsulin to an equal amount of natural substrate
resulted in only slightly greater inhibition of both converting
activities than that attained using 300 Mg/ml unlabeled precur-
sors alone .
DISCUSSION
One potential difficulty in performing studies using isolated
subcellular fractions is the possibility that the preparation
employed is contaminated with particulate or soluble compo-
nents from some portion of the subcellular apparatus other
than the fraction of interest (28). For the purposes of the
present study, it is important to know the level of contamina-
tion of the secretory granule fractions, especially with regard
to lysosomal enzymes, because they could mediate prohormone
degradation . As shown in Fig . 1, the combined secretory gran-
TABLE II
Effects of Proteinase Inhibitors on Prohormone Conversion by
Secretory Granules
Percent Inhibition
Inhibitor Proglucagon Proinsulin
Secretory granules from labeled tissue were isolated, lysed by freezing and
thawing, then incubated for 6 h in the presence or absence of inhibitors .
Hormone accumulation and percent inhibition were calculated as described
in Materials and Methods. Data represent mean values (± SE) for the
number of observations in parentheses . The presence of a negative number
signifies enhancement of conversion . The data were tested for significance
using a one-tailed Student's t test with zero (percent inhibition) as the
designated test statistic.
* P <_ 0.01 .
t P <_ 0.05 .
TABLE III
Effects of Antipain and Leupeptin on Prohormone Conversion
in Intact Tissue
* Antipain and leupeptin were included in the media of tissue preincubated
for 30 min, then incubated for 5 h with radiolabeled amino acids . Percent
accumulation of insulin and glucagon were calculated after gel filtration of
tissue extracts . Percent inhibition was calculated by comparing accumula-
tion in experimentals with insulin and glucagon accumulation in control
incubations lacking the inhibitors (see Materials and Methods) . Data are
results from single experiments, except AP + LP at 500MM, where the data
are mean (± SE) of two determinations .
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Antipain (500PM)
Chloroquine (100 MM)
DDP (300 MM)
DDP (300 MM) + DTT
69 .1 ±
8.2 ±
53 .9 ±
0.0 ±
11 .8*
3.8
16.8$
2.6
(3)
(2)
(4)
(2)
63 .8 ±
5.8 ±
50 .8 ±
22 .1 ±
10.8*
14 .0
17.3$
7.7
(3)
(2)
(4)
(2)
(5 MM)
DFP (1 mM) 8.8 ± 1 .8 (2) 7.8 :14.3 (3)
EDTA (1 mM) -6 .2 ± 8.2 (2) -26.0 ± 21 .6 (2)
Leupeptin (500 MM) 49 .2 ± 5.5* (4) 47 .5 ± 12.4$ (4)
NPGB (10gM) -3 .2 ± 7.4 (2) -1 .4 ± 5.6 (2)
PCMB (100 MM) 93 .4 ± 3.4* (3) 56 .4 ± 2.6* (3)
PCMB (1001LM) + DTT -18.8 ± 17 .3 (4) -27.8± 34 .9 (4)
(5 MM)
PCMB (1 mM) 87 .9 ± 12 .1 * (3) 57 .9± 9.0 (3)
STI (25 MM) 4.1 ±4.4 (3) 2.4± 4.4 (3)
TICK (200 MM) -4 .8 ± 14 .5 (2) -6 .5± 11 .5 (2)
TPCK (200 MM) 30 .3±8.1 (2) 29.7± 0.1 * (2)
Percent
Proglucagon
Inhibition*
Proinsulin
500 MM Antipain (AP) 25 .0 22 .1
500 pM Leupeptin (LP) 22 .4 23 .1
500MM AP +LP 36.2±1 .1 42.4±4 .0150 300
￿
600 300+300
EXOGENOUS SUBSTRATE (pg/ml)
FIGURE 7 Effects of unlabeled precursor peptides and porcine
proinsulin on conversion. Unlabeled anglerfish precursor peptides
obtained by gel filtration of tissue extracts (solid line and solid
symbols), or porcine proinsulin (dashed line and solid symbols),
were added in concentrations of 150, 300, or 600,ug/ml to aliquots
of a lysed secretory granule-exogenously radiolabeled prohormone
mixture. Equal amounts of each substrate (300 f~g/ml) in the same
incubation were also tested for inhibitory effects on proinsulin (O)
and proglucagon (0) conversion. Each combination was incubated
for 6 h at 30°C before extraction. Insulin and glucagon accumulation
were monitored in eluates after gel filtration of the extracts. Results
are expressed as mean values (±SE) for three determinations. Bovine
serum albumin at 600 jug/ml had no inhibitory effect on prohormone
conversion.
ule fractions were found to contain -10% of the total N-
acetylglucosaminidase activity, a low but significant level of
contamination. However, the possibility that contaminating
lysosomal enzymes are responsible for more than a minimal
amount of granule-mediated degradation of labeled prohor-
mones and hormones at pH 5.2 appears remote. Depletion of
both endogenously labeled and exogenously labeled prohor-
mones was accompanied by accumulation of identifiable hor-
mones afterincubation with lysed granules in acetate buffer at
pH 5.2 (Figs. 2 C, 4 C, 5, and 6). This was also true for
conversion of endogenously labeled precursors in intact gran-
ules (Fig. 4A). The fractions that contain the highest levels of
lysosomal enzyme activity, F-IIT (38%) and F-IV (18%), al-
though able to promote some protein degradation, were found
to be incapable of mediating prohormone conversion when
incubated under identical conditions. This was true for the
fraction containing the most lysosomal enzyme activity (F-IIT)
even when the fraction protein:prohormone ratio was three
times that normally used for secretory granule incubations.
These results strongly suggest that the product accumulation
monitored in incubations performed at pH 5.2 in intact and
lysed granules is primarily the result of secretory granule-
associated converting enzyme activity and not contaminating
lysosomal or cytosolic enzyme activity. The results from anal-
ysis of the products generated by granule-mediated conversion
using PAGE (Fig. 5) and reverse-phase HPLC (Fig. 6) sub-
stantiate this conclusion. Each of the insulin- and glucagon-
related products formed by granule-mediated conversion was
found as a major component in extracts of whole tissue. In
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view of the resolving power of HPLC for small peptides (19),
it seems clearthat lysed granules mediate accurate prohormone
cleavage at pH 5.2.
The pH optimum for conversion of both proinsulin and
proglucagon (Figs. 2 and 3), and prosomatostatin (10), was
found to be in the pH 4.5-5.5 range. Sorenson et al. (3) reported
that there were two pH optima for conversion of proinsulin in
rat islets, pH 5.5 and 6.5. Previous reports on the pH stability
of islet secretory granules (5, 29, 30) also correlate with our
finding that granule stability was greatest in the pH 4.5-5.5
range as well. The pH range for optimum prohormone conver-
sion differs significantly from the optima for insulin- and
glucagon-degrading enzymes found in particulate and cytosolic
fractions ofanglerfish islet. This finding further emphasizesthe
distinct differences between prohormone converting activity
and nonspecific degradation mediated by islet subcellular frac-
tions. It is noteworthy that where internal pH has been deter-
mined in secretory granules isolated from other secretory tis-
sues, it has been found to be near pH 5.5 (31, 32). It is possible
that low intragranular pH is a characteristic of secretory gran-
ules from many tissues and that control of intragranular pH
may play a role in regulation of physiologic events occurring
within secretory granules such as prohormone conversion.
The integrity of the secretory granule membrane is not
required for converting activity in vitro. Lysed granules were
shown to mediate accurate cleavage in the present study (Figs.
4-6). Kemmler et al. (5) were unable to demonstrate conversion
of exogenous proinsulin by lysed crude granule preparations
from rat islets. Sorenson et al. (3) and Ziihlke et al. (33),
however, were able to demonstrate the conversion ofexogenous
proinsulin by granule preparations isolated from rat islets. Our
findings are in accordance with the results from the latter two
investigations on proinsulin conversion and demonstrate for
the first time that exogenous proglucagon can be converted to
glucagon by lysed secretory granule preparations.
The observation that proglucagon and proinsulin converting
activities were present in the membranous components of
secretory granules even afterwashing with 100 mM KCI, which
should dissociate most adsorbed proteins (28), suggests that a
significant proportion ofthe converting enzyme(s) is membrane
bound. The activity detected in the granule supernates may be
a normal constituent of the soluble components in the granule
core. However, it seems more likely that this activity is derived
from membrane-bound converting enzyme(s) that becomes
detached or dislodged from the membranes upon repeated
freeze-thawing. This supposition is supported by the finding
that the proteolytic activities being monitored in membranous
and soluble subfractions were very similar. Reverse-phase
HPLC analysis of conversion products derived from exogenous
precursors incubated with granule membranes or supernates
demonstrated that the labeled cleavage products generated
were identical (Fig. 6). Moreover, both the membranous and
soluble converting activities were inhibited by leupeptin. Sun
et al. (6), using secretory granules isolated from rat islet, found
that only granule membranes, and not granule supernates,
converted proinsulin to insulin. These results are consistent
with the existence of a membrane-bound converting enzyme(s)
in rat islet secretory granules as well.
The significant inhibition of the conversion of both proin-
sulin and proglucagon in the presence of antipain, leupeptin,
DDP, or PCMB (Table II) indicates that the converting en-
zyme(s) is a thiol proteinase with a possible specificity for
arginine residues. A similar pattern of susceptibility to theseinhibitors was found forprosomatostatin conversion (10). That
antipain and leupeptin were capable of inhibiting conversion
in the intact cell (Table III) supports the argument that the
conversion monitored in lysed granule preparations represents
the activity that occurs in vivo. The inhibition by DDP and
PCMB was not attributable to the induction of a detectable
conformational change of the precursor peptides, because the
elution positions of proglucagon and proinsulin were un-
changed in the presence of either inhibitor. Furthermore, the
reversal of the inhibitory action of DDP and PCMB by DTT
demonstrates the participation of a reactive sulthydryl group
in the converting enzyme. Reactive sulthydryl groups are char-
acteristic of thiol proteinases (34). Kemmler et al. (5) found
that conversion of rat proinsulin by a crude granule fraction
was inhibitedin thepresence ofPCMB, suggesting the involve-
ment of a thiol proteinase in rat islet as well. The moderate
amount of inhibition of prohormone conversion caused by
TPCK is consistent with previous findings that this compound
is also highly reactive with thiol groups (35). The possible
specificity of the converting enzyme(s) for arginine residues is
suggested by the inhibition of conversion in the presence of
antipain and leupeptin. These peptides contain an arginine
aldehyde that is essential for inhibition (25). There was no
significant reduction of the proglucagon or proinsulin conver-
sion in the presence of inhibitors of metalloenzymes or serine
proteinases. DFP, the most potent serine proteinase inhibitor,
did not inhibit conversion significantly even though the con-
centration used was in excess of that sufficient to inhibit
milligram quantities of trypsin.
Because pairs of basic amino acid residues have been found
at cleavage sites in most polypeptide prohormones, theinvolve-
ment of enzymes with specificity for basic residues in the
processing of proinsulin has been suggested by a number of
investigators. Proposed converting enzymes include "trypsin-
like" enzymes (5, 33, 36), cathepsin B (37, 38), pancreatic
kallikrein kininase (39), and plasminogen activator-plasmin
(40). The role of enzymes with similar specificity in the con-
version of anglerfish islet prohormones hasbeen demonstrated
by investigations in which trypsin treatment of anglerfish pro-
glucagon (15, 41) and proinsulin (15, 42) yielded peptides
having some of the characteristics of glucagon and insulin,
respectively. However, on the basis of the proteinase inhibitor
data presented in this paper and in a previous paper (10), it is
concluded that none of the converting enzymes that have been
implicated previously is involved in the conversion of angler-
fish prohormones by secretory granules. Both kallikrein (43)
and plasminogen activator(44) are inhibited in the presence of
DFP and NPGB, neither of which affected conversion of
anglerfish prohormones. The involvement of trypsin per se is
also negated by the failure of DFP, STI, and TLCK to inhibit
conversion. In view of the pH optimum forconversion and the
susceptibility of the converting process to thiol proteinase
inhibitors, the possibility arises that the anglerfish converting
enzyme(s)maybe cathepsin B. This lysosomalthiol proteinase
is susceptible to inhibition by PCMB, antipain, and leupeptin
and has its greatest enzymatic activity at pH 3.5-6.0 (26, 27).
Moreover, the results from two recent studies have demon-
strated that cathepsin B catalyzed the conversion of proinsulin
into insulinlike components (37, 38). In lysed anglerfish islet
secretory granules, however, neitherproglucagon nor proinsu-
lin conversion was inhibited in the presence of chloroquine or
TLCK, both of which are powerful inhibitors of cathepsin B
(26, 27). These data indicate that the converting activity ob-
served is mediated by an enzyme other than cathepsin B, but
which has cleavage specificity and a pH optimum similar to
those of cathepsin B.
The data from the present study do not provide any infor-
mation regarding thepossibility that atwo-step cleavage proc-
ess may be involved in anglerfish islet prohormone conversion.
It has been demonstrated forseveral polypeptide prohormones
that the combined action of trypsin and carboxypeptidase B
are required to effect complete prohormone-to-hormone cleav-
agein vitro (45-47). Because ofitsprimary structure, anglerfish
proinsulin can be converted to insulin with single cleavages at
either end of the C-peptide by a trypsinlike enzyme alone (42,
48). Although mammalian "proglucagons" (46) and glicentin
(49) requirea two-step cleavage mechanism, theprimarystruc-
ture of anglerfish proglucagon is unknown. It is therefore not
possible to state whether the inhibitors that interfered with
proglucagon converting activity were inhibiting the action of
one or more than one enzyme.
It is proposed that theconverting enzyme(s) in the anglerfish
islet is a unique intracellular proteinase that may be granule
membrane-associated and has the characteristics of a thiol
proteinase with cleavage specificity for basic amino acid resi-
dues. Because conversion of the prohormones is also detected
in microsome fractions (7, 10, 13), it is conceivable that the
converting enzyme(s) is synthesized along with the
(pre)prohormones in the rough endoplasmic reticulum and
becomes associated with membranous components during or
soon aftersynthesis. The resultsfrom theexperiments in which
the ability of porcine proinsulin to inhibit exogenous conver-
sion was assessed are consistent with the possibility that the
converting enzyme(s) requires the presence of a segment of
polypeptide in addition to the dibasic residue sites for recog-
nition and/or binding to the prohormones (Fig. 7). Porcine
proinsulin was found to be significantly less potent as an
inhibitor of conversion than equal microgram amounts of
natural substrates. Because they are all larger than porcine
proinsulin, the mix ofnaturalsubstrates provided fewerdibasic
residue sites (fewer substrate molecules) for enzyme action in
theseexperiments. Because porcineproinsulin, whichpresented
more dibasicresidue-containing moleculesto thesystem,com-
peted less well with labeled natural substrates than the unla-
belednaturalsubstrates, the results suggest that the converting
enzyme(s) recognizes and/or requires more than just dibasic
residues forperforming its function.
It remains to be determined whether there are separate
converting enzymes for each islet prohormone. If there are
separate converting enzymes for each islet prohormone, then
each has thesame sensitivity to proteinase inhibitors (Table II)
and a similar pH optimum (Figs. 2 and 3; reference 10). To
completely resolve this and otherquestions regarding the sub-
cellular conversion of anglerfish proglucagon and proinsulin,
it will be necessary to isolate and characterize the converting
enzyme(s).
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